Horizon Space Acquisition I Corp. Enters Merger Agreement

Horizon Space Acquisition I Corp. has announced its entry into a business combination agreement with ArcheNova Technology Co., Ltd. This strategic move is set to transform Horizon from a blank check company into a fully operational public entity.

The merger agreement, effective October 12, 2026, involves a two-step process where Horizon will first merge with ArcheNova's subsidiary, followed by a second merger with ArcheNova Biotech Corp. Upon completion, both Horizon and ArcheNova Biotech will become wholly-owned subsidiaries of the newly formed public company, referred to as PubCo.

This merger is significant as it indicates a continued trend towards consolidation within the blank check company sector. As more companies pursue similar paths, the competitive landscape may shift, prompting other players in the industry to reassess their strategies.

About Horizon Space Acquisition I Corp.

Horizon Space Acquisition I Corp., classified under the SIC code 6770 for Blank Checks, is a Cayman Islands exempted company. The firm operates on the OTC exchange under the tickers HSPOF, HSPUF, and HSPWF. As an emerging growth company, Horizon focuses on acquiring and merging with businesses in the technology and aerospace sectors.

What the Filing Says

The recent filing outlines the details of the business combination agreement, stating, "Merger Sub I will merge with and into HSPO, with HSPO surviving the merger and becoming a wholly-owned subsidiary of PubCo." The filing also indicates that upon closing, shareholders of both HSPO and ArcheNova will receive ordinary shares of PubCo as consideration.

Impact

This merger will impact various stakeholders, including shareholders of Horizon and ArcheNova, who will become shareholders of PubCo. Additionally, the deal may influence other blank check companies looking to establish themselves in the market.

What's Next

The filing does not specify the next steps following this announcement, but it is expected that shareholder approvals and regulatory filings will be necessary to consummate the merger.